Laman UtamaABUS • NASDAQ
add
Arbutus Biopharma Corp
$3.51
Selepas Waktu Dagangan:(0.85%)+0.030
$3.54
Tutup: 22 Nov, 7:22:39 PTG GMT-5 · USD · NASDAQ · Penafian
Tutup sebelumnya
$3.46
Julat hari
$3.45 - $3.53
Julat tahun
$1.79 - $4.72
Permodalan pasaran
665.12J USD
Bilangan Purata
910.00K
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
NASDAQ
Dalam berita
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (USD) | Sep 2024info | Perubahan T/T |
|---|---|---|
Hasil | 1.34J | -71.25% |
Perbelanjaan pengendalian | 4.54J | -22.34% |
Pendapatan bersih | -19.72J | 1.92% |
Margin untung bersih | -1.47K | -241.18% |
Pendapatan bagi setiap syer | -0.14 | 15.57% |
EBITDA | -17.14J | 18.34% |
Kadar cukai berkesan | — | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (USD) | Sep 2024info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 127.79J | -4.76% |
Jumlah aset | 140.44J | -11.47% |
Jumlah liabiliti | 33.55J | -14.64% |
Jumlah ekuiti | 106.89J | — |
Syer tertunggak | 189.49J | — |
Harga kepada buku | 6.18 | — |
Pulangan pada aset | -29.07% | — |
Pulangan pada modal | -35.87% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (USD) | Sep 2024info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | -19.72J | 1.92% |
Tunai daripada operasi | -20.74J | 4.81% |
Tunai daripada pelaburan | -11.99J | -214.93% |
Tunai daripada pembiayaan | 1.78J | 5.59% |
Perubahan bersih dalam tunai | -30.94J | -220.11% |
Aliran tunai bebas | -10.88J | 21.66% |
Perihal
Arbutus Biopharma Corporation is a publicly traded Canadian biopharmaceutical company with an expertise in liposomal drug delivery and RNA interference, and is developing drugs for hepatitis B infection.
It is headquartered in Warminster, Pennsylvania. The company was formerly known as Tekmira, which was spun out of Inex Pharmaceuticals in 2007. Wikipedia
Diasaskan
2007
Tapak web
Pekerja
73
